Clin2
NCT06902922Worth exploringNot yet recruiting

Effects of tricuspid valve repair on gut health

Tricuspid Regurgitation (TR)

Part of Heart & circulation clinical trials.

This study looks at how fixing a severe leaky tricuspid valve (T-TEER) affects your gut bacteria and digestive health. It aims to see if correcting this heart valve issue can improve your digestion and overall well-being.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
150 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You are 18 years or older and able to give consent
  • You have severe tricuspid regurgitation (a leaky heart valve on the right side) that is being treated with a minimally invasive valve repair procedure (T-TEER)
  • You do not have severe leakage in your mitral valve (another heart valve) at the same time
  • You have not had heart surgery or a heart procedure in the last 6 months, and you do not need coronary artery treatment
  • You do not have any active gut, inflammatory, or immune diseases, and you have not had gut surgery or taken antibiotics/probiotics recently
  • You are not on kidney dialysis and do not have active cancer

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07578129Not yet recruiting
Registry for tricuspid valve repair in heart failure

This study tracks people with a leaking tricuspid valve and weakened heart pumping to see how a minimally invasive repair procedure affects their health over time. It aims to improve treatment for those with heart failure.

NCT07140562Recruiting
Catheter-based repair for severe tricuspid valve leak

This study tests a new catheter-based device to repair a leaky tricuspid heart valve (tricuspid regurgitation) in people who still have symptoms like shortness of breath or swelling despite taking heart medications. The goal is to see if the procedure is safe and can help reduce the leak.

Asunción
NCT06877520Recruiting
Study of a new device for fixing leaky tricuspid valve

This trial tests a new, less-invasive device called 'Pivot Extend' for people with a severe leaky tricuspid valve (tricuspid regurgitation) who still have symptoms despite taking medicines. The goal is to see if the device can safely help reduce the leak and improve symptoms.

Tbilisi, K'alak'i T'bilisi
NCT07528326Not yet recruiting
Tricuspid valve repair for severe leakage

This trial tests a new device to fix a leaky tricuspid valve in the heart, which can cause symptoms like swelling and shortness of breath. The goal is to see if the device helps people who still have symptoms despite taking medication.

NCT07586995Recruiting
Safety and performance study of the TriClip heart valve repair device

This study tracks how well the TriClip device works and how safe it is after it's placed in your heart to repair a leaky valve. You'll attend follow-up visits so doctors can monitor your recovery and device function over time.

Phoenix, Arizona
NCT05595187Not yet recruiting
Tricuspid valve repair alongside left heart surgery

This study looks at whether fixing the tricuspid valve at the same time as left heart surgery is beneficial for patients with mild tricuspid regurgitation. It may help improve heart function and reduce future symptoms.

Nanjing

Hear when a new Tricuspid Regurgitation (TR) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.